Page last updated: 2024-12-11

adrogolide hydrochloride

Description

adrogolide hydrochloride: the diacetyl prodrug of A-86929; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6918298
CHEMBL ID2146092
SCHEMBL ID1229151
MeSH IDM0577649

Synonyms (21)

Synonym
das-431
abt-431
a-93431.1
adrogolide hydrochloride
adrogolide hydrochloride (usan)
D02775
abt 431
das 431
unii-69mg3oza0h
adrogolide hydrochloride [usan]
adrogolide hcl
(5ar,11bs)-4,5,5a,6,7,11b-hexahydro-2-propylbenzo(f)thieno(2,3-c)quinoline-9,10-diol diacetate (ester), hydrochloride
a 93431.1
benzo(f)thieno(2,3-c)quinoline-9,10-diol, 4,5,5a,6,7,11b-hexahydro-2-propyl-, diacetate (ester), hydrochloride, (5ar-trans)-
(5ar,11bs)-4,5,5a,6,7,11b-hexahydro-2-propylbenzo(f)thieno(2,3-c)quinoline-9,10-diol, diacetate (ester), hydrochloride
69mg3oza0h ,
CHEMBL2146092
(5ar,11bs)-4,5,5a,6,7,11b-hexahydro-2-propylbenzo[f]thieno[2,3-c]quinoline-9,10-diol diacetate (ester), hydrochloride
SCHEMBL1229151
166591-11-3 (hcl)
AKOS040750152

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" Following intratracheal instillation of the drug solution, the lung bioavailability was found to be approximately 75% in dogs."( Pulmonary delivery of a dopamine D-1 agonist, ABT-431, in dogs and humans.
Adjei, AL; Bertz, RJ; El-Shourbagy, T; Marsh, KC; Zheng, Y, 1999
)
0.3
" Adrogolide undergoes a high hepatic "first-pass" metabolism in man after oral dosing and, as a result, has a low oral bioavailability (approximately 4%)."( Adrogolide HCl (ABT-431; DAS-431), a prodrug of the dopamine D1 receptor agonist, A-86929: preclinical pharmacology and clinical data.
Giardina, WJ; Williams, M, 2001
)
0.31

Dosage Studied

ExcerptRelevanceReference
" Adrogolide improves behavioral disability and locomotor activity scores in MPTP-lesioned marmosets, a model of Parkinson's disease (PD), and shows no tolerance upon repeated dosing for 28 days."( Adrogolide HCl (ABT-431; DAS-431), a prodrug of the dopamine D1 receptor agonist, A-86929: preclinical pharmacology and clinical data.
Giardina, WJ; Williams, M, 2001
)
0.31
"A 60% ethanol formulation of 50 mg/mL ABT-431 was used to prepare unit dosage forms containing 40 microL of formulation."( Evaluation of the AERx pulmonary delivery system for systemic delivery of a poorly soluble selective D-1 agonist, ABT-431.
Adjei, AL; Bertz, RJ; Blanchard, JD; Farr, SJ; Gonda, I; Lee, RY; Lloyd, PM; Okikawa, J; Okumu, FW; Queirolo, A; Rubsamen, R; Woods, CM, 2002
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's6 (46.15)18.2507
2000's7 (53.85)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.33

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.33 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index4.28 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.33)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials5 (38.46%)5.53%
Reviews1 (7.69%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (53.85%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
chemdatabank.com